Velocity Composites gains £1.5 million investment boost
11 Oct 2023
Photo Credit: Velocity Composites
Aerospace composites manufacturer Velocity Composites (Burnley, U.K.) has received an additional £1.5 million from Seneca Partners (Newton-le-Willows, U.K.) as part of a successful £6.6 million funding round. This latest investment will enable the company to accelerate its growth in the U.K. and overseas following the opening of its plant in Alabama, to add to its U.K. sites in Burnley and Fareham.
Seneca Partners is an existing shareholder in AIM-quoted Velocity through its £50 million EIS fund. It is an award-winning specialist SME investment business and the founding member of a network of companies which operate across the North of England.
“We are delighted Seneca have backed us again as we continue to grow,” Andy Beaden, chairman of Velocity Composites, says. “Their industry knowledge and reputation as a leading growth capital investor has excited us about having them on board for the next leg of our journey.”
The proceeds of the fundraise will support Velocity to scale the business, create further fund working capital requirements as well as make further investment in people, mainly based in its Burnley facility through key appointments in engineering, software and business development.
Velocity Composites manufactures advanced carbon fiber and ancillary material kits for use in the aerospace and associated industries from its sites in the U.K. and the U.S. The company uses its process knowledge, business processes and proprietary software to reduce the amount of material required by its customers and also reduce the associated material waste when making aircraft parts.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.